Sarcoma Clinical Trials
Recruiting sarcoma studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat sarcoma. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting sarcoma studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting sarcoma trials
Information-providing Chatbot
Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on Recurrence Rate in Patients With Primary Extremity Sarcoma
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention
Combination Immunotherapy Targeting Sarcomas
Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas
CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
Tumor-Lymph Node Mapping
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas
Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC)
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Distance-Based Exercise to Preserve Function and Prevent Disability
Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patients
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Sarcoma Surgery Wound Complications Comparing Usual Versus Negative Pressure Dressing
Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)
Pediatric Radiation Therapy Registry
Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.
DESTINY-PANTUMOUR04
Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma Surgery
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas
Fluorescence-Guided Optimization of Sarcoma Margins
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
IDOV-Immune for Advanced Solid Tumors
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma
Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
PROMIS and Mobility Evaluation in Sarcoma Patients
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
SLV-154 Treatment of Metastatic Solid Tumors
Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma
Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma
Sarcoma clinical trials — common questions
Are sarcoma clinical trials free to join?
Yes. Participating in a sarcoma clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a sarcoma clinical trial?
Each sarcoma study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a sarcoma trial near me?
Use the location controls above. We'll show recruiting sarcoma trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many sarcoma trials are recruiting right now?
We're currently tracking roughly 71 recruiting sarcoma trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.